Musclepharm Corp (MSLP) financial statements (2020 and earlier)

Company profile

Business Address 4721 IRONTON STREET
DENVER, CO 80239
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments65716 
Cash and cash equivalents65715 
Short-term investments    0 
Receivables17132217143
Inventory, net of allowances, customer advances and progress billings69132116
Inventory69132116 
Prepaid expense0   3
Derivative instruments and hedges, assets    0 
Prepaid expense and other current assets0
Other current assets    1
Other undisclosed current assets126851
Total current assets:30294746455
Noncurrent Assets
Property, plant and equipment237831
Long-term investments and receivables  1   
Long-term investments  1   
Intangible assets, net (including goodwill)1297
Intangible assets, net (excluding goodwill)1297  
Prepaid expense    5
Regulated entity, other noncurrent assets     0
Deferred costs    00
Other noncurrent assets00000
Prepaid expense and other noncurrent assets0
Other undisclosed noncurrent assets   5(0)(0)
Total noncurrent assets:35172082
TOTAL ASSETS:34346466527
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:201952352812
Accounts payable12104028  
Accrued liabilities89137  
Other undisclosed accounts payable and accrued liabilities    2812
Debt   804
Derivative instruments and hedges, liabilities    1 
Restructuring reserve119 
Other undisclosed current liabilities8196(0)30
Total current liabilities:283867433217
Noncurrent Liabilities
Long-term debt and lease obligation1706000
Long-term debt, excluding current maturities1706000
Capital lease obligations0 00  
Liabilities, other than long-term debt000   
Restructuring reserve000   
Other undisclosed noncurrent liabilities1  (0)  
Total noncurrent liabilities:1817000
Total liabilities:463974433217
Stockholders' equity
Stockholders' equity attributable to parent, including:(13)(5)(10)2320(10)
Common stock000000
Treasury stock, value(10)(10)(10)(10)(1)(0)
Additional paid in capital16015614812910355
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)
Accumulated deficit(162)(151)(148)(96)(82)(64)
Other undisclosed stockholders' equity attributable to parent    0 
Total stockholders' equity:(13)(5)(10)2320(10)
TOTAL LIABILITIES AND EQUITY:34346466527

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
10213216717711167
Cost of revenue
(Cost of Goods and Services Sold)
(72)(88)(110)(121)(78)(53)
Gross profit:304457563314
Operating expenses(38)(53)(107)(75)(67)(36)
Other undisclosed operating income    1913
Operating loss:(7)(9)(50)(19)(14)(9)
Nonoperating income (expense)(5)(2)(2)6(3)(10)
Investment income, nonoperating(1)  6(0)(4)
Debt instrument, convertible, beneficial conversion feature 10   
Other nonoperating income (expense)(4)(2)(2)6(0)0
Interest and debt expense(3)(1) (0) (0)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes48(0)0  
Loss from continuing operations before equity method investments, income taxes:(11)(3)(52)(14)(18)(19)
Other undisclosed loss from continuing operations before income taxes(0)     
Loss from continuing operations before income taxes:(11)(3)(52)(14)(18)(19)
Income tax expense (benefit)0(0)(0)(0)(0)7
Net loss:(11)(3)(52)(14)(18)(12)
Other undisclosed net loss attributable to parent(0)    (7)
Net loss available to common stockholders, diluted:(11)(3)(52)(14)(18)(19)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(11)(3)(52)(14)(18)(12)
Other comprehensive loss    (0)(0)
Other undisclosed comprehensive loss     (7)
Comprehensive loss:(11)(3)(52)(14)(18)(19)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)(0)  
Comprehensive loss, net of tax, attributable to parent:(11)(3)(52)(14)(18)(19)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: